Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prevnar Dosing Restrictions May Be Lifted Soon; Two-Step Process Likely

Executive Summary

Wyeth's Prevnar supply could be sufficient for the Centers for Disease Control & Prevention to begin restoring the pneumococcal vaccine's recommended four-dose regimen this summer
Advertisement

Related Content

CDC recommends reinstating third Prevnar dose
CDC recommends reinstating third Prevnar dose
Wyeth Prevnar Batches To Ship Soon; Contract Fill/Finish Facility Approved
Wyeth Offering FluMist Coupons; Prevnar Supply Issue “Resolved,” FDA Says
Advertisement
UsernamePublicRestriction

Register

PS044132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel